|
|
 |
Program of the conference:
|
|
Monday, Sept 29, 2008
|
|
13.00 h
|
Welcome
|
Prof. Dr. A. Buschauer
|
|
13.10-14.10 h
|
Structure-based approaches towards new antimalarials
|
Prof. Dr. Francois Diederich,
ETH Zurich, Switzerland
|
|
14.10-15.10 h
|
Protein-Ligand Interactions as the Bases of Drug Design
|
Prof. Dr. Gerhard Klebe,
University of Marburg, Germany
|
|
Coffee break
|
|
|
|
15.40-16.40 h
|
Chemical similarity and biological activity
|
Prof. Dr. Hugo Kubinyi,
University of Heidelberg, Germany
|
|
16.40-17.40 h
|
Predictions and machine learning: a personal viewpoint of GPCR activation
|
Prof. Dr. Tudor Oprea,
University of New Mexico, Albuquerque, NM, USA
|
| Coffee break |
|
|
| 18.00-19.00 h |
From adenine to ATP: purinergic G protein-coupled receptors |
Prof. Dr. Christa Müller,
University of Bonn, Germany |
| 19.00-19.30 h |
Oral poster presentation |
|
| 19.30 h |
Poster session / Beer and bretzel |
|
|
|
Tuesday, Sept 30, 2008
|
| 8.30-9.30 h |
Ligand-specific GPCR conformations |
Prof. Dr. Jillian Baker,
University of Nottingham, UK |
| 9.30-10.30 h |
Regulation of GPCR signaling and trafficking |
Prof. Dr. JoAnn Trejo,
University of California, San Diego, CA, USA |
| Coffee break |
|
|
| 11.00-12.00 h |
Medicinal Chemistry experiences with GPCRs |
Dr. Klaus Rudolf,
Boehringer Ingelheim, Biberach, Germany |
| 12.00-12.30 h |
Oral poster presentation |
|
| Lunch break |
|
|
| 13.45-14.45 h |
Protein kinases: the selectivity problem |
Prof. Dr. Stefan Laufer,
University of Tübingen, Germany |
| 14.45-15.45 h |
Akt inhibitors for cancer therapy - evolution of enzyme inhibitor classes |
Dr. George Hartman,
Merck & Co., Westpoint, PA, USA |
| 15.45-16.00 h |
Oral poster presentation |
|
| Coffee break |
|
|
| 16.30-17.30 h |
Successful developments in the field of protease inhibitors |
Prof. Dr. Torsten Steinmetzer,
University of Marburg, Germany |
| 17.30-18.30 h |
Lead identification and optimization of glycogen phosphorylase inhibitors |
Dr. Karl-Heinz Baringhaus,
Sanofi-Aventis, Frankfurt, Germany |
| 18.30-18.45 h |
Oral poster presentation |
|
| 18.45-20.00 h |
Poster session |
|
| 20.00 h |
Barbecue at the University of Regensburg |
|
|
Wednesday, Oct 01, 2008
|
| 8.30-9.45 h |
Biomarkers: vision and reality |
Prof. Dr. Martin Schneider,
Bayer-Schering Pharma, Berlin, Germany |
| 9.45-10.45 h |
Blood-brain barrier |
Prof. Dr. Gert Fricker,
University of Heidelberg, Germany |
| Coffee break |
|
|
| 11.15-12.15 h |
Application of an operational model to the understanding of the allosteric interactions of calcimimetics to the calcium sensing receptor |
Dr. Jeff Reagan,
Amgen, South San Francisco, CA, USA |
| 12.15-13.15 h |
Natural products: Is there more to gain than a lead structure? |
Prof. Dr. Ludger Wessjohann,
Leibniz Institute for Plant Biochemistry, Halle, Germany |
| 13.15 h |
Concluding remarks |
|
|
|
|
